dl-Chaminsaeure | 38859-06-2

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 异戊烯醇脂质
• 英文名称: dl-Chaminsaeure
• 英文别名: Chaminsaeure (chaminic acid)；7,7-Dimethylbicyclo[4.1.0]hept-3-ene-3-carboxylic acid
• CAS: 38859-06-2
• 化学式: C₁₀H₁₄O₂
• 分子量: 166.22
• InChiKey: CKSIWMCJGLFKSZ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.1
• 重原子数：
  12
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.7
• 拓扑面积：
  37.3
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  7,7-二甲基二环[4.1.0]庚-3-烯-4-甲醛 、 氧化银 以47%的产率得到
  参考文献：
  名称：

  VESELOVSKIJ, V. V.;MAKAROVA, Z. G.;LUTSENKO, A. I.;SHPIRO, N. A.;ZHULIN, +, IZV. AN CCCP. CEP. XIM.,(1988) N 4, 810-815

  摘要：

  DOI：

文献信息

• Compounds for Treating Cannabinoid Toxicity and Acute Cannabinoid Overdose
  申请人：MAKScientific, LLC

  公开号：US20220033393A1

  公开（公告）日：2022-02-03

  The present invention relates to novel compounds that can act as antidotes for treating “Acute Cannabinoid Overdose” produced by classical cannabinoids such as Δ 9 -tetrahydrocannabinol (THC) and several synthetic psychoactive cannabinoids (SPCs). The cannabis constituent THC exerts its psychotropic effects via CB1 receptor activation and SPCs mimic the effects of THC with higher potency and severe neurotoxicity. Compounds disclosed in this invention, their enantiomers, diastereomers, geometric isomers, racemates, tautomers, rotamers, atropisomers, metabolites, N-oxides, salts, solvates, hydrates, isotopic variations and their polymorphic forms can be therapeutically useful in an emergency setting for counteracting the intoxicating effects of acute THC ingestion and SPC overdose. Also, aspects of the invention are concerned with pyrazoles, imidazoles, triazoles, thiazoles, oxazoles, dihydropyrazoles, pyrrolidinones, azetidines, oxyazetidines and azaspiro[3.3]heptanes with unique pharmacokinetic and pharmacodynamic properties for treating “Acute Cannabinoid Overdose”.

  本发明涉及一种新型化合物，可以作为治疗由经典大麻素（如Δ9-四氢大麻酚（THC））和几种合成精神活性大麻素（SPCs）产生的“急性大麻素过量”的解毒剂。大麻成分THC通过CB1受体激活发挥其精神活性作用，而SPCs则模拟THC的效果，具有更高的效力和严重的神经毒性。本发明披露的化合物及其对映体、二对映体、几何异构体、拉克酸盐、互变异构体、转型异构体、异构异构体、代谢物、N-氧化物、盐、溶剂合物、水合物、同位素变体及其多态形式在急诊情况下可以在对抗急性THC摄入和SPC过量的中毒作用方面具有治疗用途。此外，本发明涉及吡唑烷、咪唑烷、三唑烷、噻唑烷、噁唑烷、二氢吡唑烷、吡咯烷酮、氮杂环丁烷、氧杂环丁烷和氮杂螺[3.3]庚烷等具有独特药代动力学性能的化合物，用于治疗“急性大麻素过量”。
• CANNABINERGIC NITRATE ESTERS AND RELATED ANALOGS
  申请人：Northeastern University

  公开号：US20160002195A1

  公开（公告）日：2016-01-07

  The present technology relates to novel cannabinergic nitrate esters and related analogs, process of preparation, pharmaceutical compositions and their methods of use as medicaments, pharmacological tools and/or biomarkers. The novel cannabinergic nitrate ester compounds provide medicaments useful in treating a variety of diseases and medical disorders.

  本技术涉及新型大麻素硝酸酯及其类似物、制备方法、制药组合物及其作为药物、药理工具和/或生物标志物的使用方法。这些新型大麻素硝酸酯化合物提供了治疗各种疾病和医学障碍的有用药物。
• Novel Cannabinergic Nitrate Esters and Related Analogs
  申请人：Makriyannis Alexandros

  公开号：US20160096822A1

  公开（公告）日：2016-04-07

  Biologically active cannabinergic nitrate esters and related analogs, process of preparation, pharmaceutical compositions and their methods of use as medicaments, pharmacological tools or biomarkers. Pharmaceutical compositions may include one or more of the nitrate ester compounds. Medicaments include one or more of the cannabinergic nitrate ester compounds and are useful in treating a variety of diseases. A method of treating, preventing or reducing the severity of a condition includes administering at least one of the disclosed nitrate ester compounds to an individual or animal in need thereof.

  具有生物活性的大麻素硝酸酯及其类似物、制备方法、制药组合物及其作为药物、药理工具或生物标志物的使用方法。制药组合物可以包括一个或多个硝酸酯化合物。药物包括一个或多个大麻素硝酸酯化合物，可用于治疗各种疾病。一种治疗、预防或减轻症状的方法包括向需要的个体或动物中至少给予所披露的硝酸酯化合物之一。
• METHOD FOR PRODUCING OXYGEN-CONTAINING COMPOUND
  申请人：Sumitomo Chemical Company, Limited

  公开号：EP1609777A1

  公开（公告）日：2005-12-28

  It is provided that a method for producing an oxygen-containing compound, characterized in that an olefin compound having a carbon-carbon double bond which is bonded to a methyl or methylene group is reacted with an organic hydroperoxide in the presence of an ionic liquid and a selenium compound.

  本发明提供了一种生产含氧化合物的方法，其特征在于：在离子液体和硒化合物的存在下，使具有碳碳双键并与甲基或亚甲基键合的烯烃化合物与有机过氧化氢反应。
• Cannabinergic nitrate esters and related analogs
  申请人：University of Connecticut

  公开号：US10053444B2

  公开（公告）日：2018-08-21

  Biologically active cannabinergic nitrate esters and related analogs, process of preparation, pharmaceutical compositions and their methods of use as medicaments, pharmacological tools or biomarkers. Pharmaceutical compositions may include one or more of the nitrate ester compounds. Medicaments include one or more of the cannabinergic nitrate ester compounds and are useful in treating a variety of diseases. A method of treating, preventing or reducing the severity of a condition includes administering at least one of the disclosed nitrate ester compounds to an individual or animal in need thereof.

  具有生物活性的大麻素硝酸酯和相关类似物、制备工艺、药物组合物及其作为药物、药理学工具或生物标记物的使用方法。药物组合物可包括一种或多种硝酸酯化合物。药物包括一种或多种大麻素硝酸酯化合物，可用于治疗多种疾病。一种治疗、预防或减轻病情严重程度的方法包括向有需要的个体或动物施用至少一种所公开的硝酸酯化合物。